Re: OCRX liquidity http://finance.yahoo.com/news/ocera-therapeutics-reports-fourth-quarter-140500194.html As of December 31, 2015, Ocera had cash, cash equivalents and investments of $43.3 million… Ocera expects net use of cash for 2016 to be between $26 million to $30 million and expects that it will have sufficient cash to fund operations into the second half of 2017 based on its current operating plan. If Ocera receives the second $10.0 million tranche of its debt facility [see #msg-115827192], which is subject to the achievement of certain financial and clinical milestones, the Company expects that it will have cash to fund its operations into late 2017.